What lung cancer mutations have approved targeted therapies?
In the United States there are four genetic changes where we have FDA-approved therapies. So these are EGFR which is found in about 10-15 percent of patients, ALK which is 3-5 percent, ROS1 which is 1-2 percent, and BRAF which is a very specific genetic change which is about 2 percent.
For more information and to see the full recorded discussion, visit Lung.org/tumor-testing-videos.
Generously supported by AstraZeneca, Bristol-Myers Squibb, Foundation Medicine, Pfizer, and Merck & Co., Inc.
Page last updated: March 22, 2020